AIDS treatment has won major breakthroughs in gene editing technology
The research team at Temple University in the United States uses the CRISPR/CAs9 gene editing technology to remove the HIV-1 virus from T cells that play an important role in the human immune response, so that it can no longer infect other healthy cells. The technology is said to be safe not to cause any toxic effects.
Recognized as the “Hand of Godâ€, the third-generation gene editing technology CRISPR/Cas9 provides a promising genetic tool for the treatment of global problems such as cancer, AIDS, blood diseases and genetic diseases, and has achieved many amazing results. The commercialization process of CRISPR technology is accelerating, and the first gene therapy based on CRISPR technology will also enter clinical trials within 1-2 years. The disruptive and future growth space of CRISPR gene editing technology is worthy of optimism.
In the A-share company with CRISPR/Cas9 gene editing technology, Jinjia Co., Ltd. cooperates with Sun Yat-sen University to apply genetic modification of thalassemia disease using CRISPR/Cas9 technology. Aoyang Technology's shareholding company, Jikai Gene, owns the CRISPR/Cas9 lentivirus system and TALLEN technology.
Temporary Flood Boxwall,Temporary Flood Barrier,Quick Flood Barrier,Flood Barrier Door
Denilco Environmental technology(Suzhou)Co., Ltd. , https://www.wflood.com